This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our PRIVACY POLICY for more information on the cookies we use and how to delete or block them.
  • Capping of payable R&D credits for SMEs
Article:

Capping of payable R&D credits for SMEs

20 November 2020

On the 12 November 2020, the government published draft legislation to implement a Research & Development (R&D) tax credit PAYE cap for small and medium enterprises (SMEs). Companies receiving repayable R&D tax credits under the SME scheme might be affected by these new rules: the legislation will become active for accounting periods beginning on or after 1 April 2021.

Background to the changes

The original consultation on this issue “Preventing abuse of the R&D tax relief for SMEs” was published in 2018 and the government’s proposed solution, capping the repayable R&D credit at a multiple of the PAYE paid by the SME claimant had been scheduled to come into effect on 1 April 2020. However, this was delayed due to concerns over the impact it would have on genuine R&D claims by small companies: many respondents (including BDO) pointed out that genuine start up R&D businesses, particularly in the technology and sciences sectors would be disproportionately affected. The uncertainty caused by the COVID-19 pandemic was also a clear reason to delay.

The detailed legislation that has now been unveiled shows that the government has taken steps to address the concerns that a number of small businesses that undertake valuable and genuine R&D activities could have been inadvertently penalised by the new legislation. The published legislation now includes a number of tests and exemptions for companies where, if satisfied, they will not be caught by the new rules.

New exemptions to the PAYE cap

The new rules will include a £20,000 claim threshold, below this amount the cap will not apply – so smaller claimants will be unaffected by the new rules. While this will come as a blow for some larger claimants, it means that the new rules are now only targeting companies that subcontract large amounts of their R&D to third parties.

Even where a large amount of R&D work is subcontracted out, the government have now also included new features to minimise the impact on companies undertaking genuine R&D. An R&D claim, of any size, will not be capped if the claimant company meets two tests: 

  1. That the company’s employees are creating, preparing to create or actively managing intellectual property
  2. That expenditure on work subcontracted to a related party, or externally provided workers provided by a related party, is less than 15% of the claimants overall R&D expenditure. 

These new conditions are similar to requirements already present in the legislation for the UK patent box regime. However, in this instance the test is focussed on the management activities around the exploitation and development of intellectual property rather than its ownership. These rules have been designed to exempt companies with low PAYE and NIC, but which are nevertheless themselves engaged in genuine, substantial R&D.

Another helpful addition to the new rules is that a company will be able to include related party PAYE and NIC liabilities attributable to the R&D project when calculating the cap and these will be subject to the 300% multiplier.

Future claims

We welcome these sensible additions to the draft legislation to ensure that genuine R&D activities in small companies is still rewarded via the SME scheme. However, we recommend all SME companies that benefit from a payable credit from their R&D claims examine the impact that these new rules may have on their future claims. Where the new rules are anticipated to affect projected cashflows, it may be appropriate to adapt the manner in which R&D activities are conducted to ensure your business model remains viable. 

For help and advice on structuring your R&D projects and managing your R&D claims, please get in touch with your usual BDO contact or Cathy Kelly.